[1]
A. S. Alkunani, L. G. Shareef, and A. Z. Al Arajy, “Claudin-6 (CLDN6) and Folate Receptor Alpha (FRα) Targeted Antibody-Drug Conjugates: Bypassing Platinum Resistance and Tumor Heterogeneity in High-Grade Serous Ovarian Carcinoma”, Al-Rafidain J Med Sci, vol. 11, no. 2, pp. 140–151, Oct. 2026.